TriSalus Life Sciences, Inc. Research and Development Expense
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- TriSalus Life Sciences, Inc. research and development expense for the quarter ending 2026-06-30 was $3.14M, a 14.52% decline year-over-year.
- TriSalus Life Sciences, Inc. research and development expense for the quarter ending 2026-03-31 was $3.22M, a 6.45% increase year-over-year.
- TriSalus Life Sciences, Inc. research and development expense for the quarter ending 2025-12-31 was $2.57M, a 13.15% decline year-over-year.
- TriSalus Life Sciences, Inc. research and development expense for the quarter ending 2025-09-30 was $5.18M, a 22.68% increase year-over-year.
- TriSalus Life Sciences, Inc. research and development expense for fiscal 2025 was $14.96M, a 15.39% decline from fiscal 2024.
- TriSalus Life Sciences, Inc. research and development expense for fiscal 2024 was $17.69M, a 40.71% decline from fiscal 2023.
- TriSalus Life Sciences, Inc. research and development expense for fiscal 2023 was $29.84M, a 39.69% increase from fiscal 2022.
- TriSalus Life Sciences, Inc. research and development expense for fiscal 2022 was $21.36M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.14M 10-Q · filed 2026-08-06 | $6.35M 10-Q · filed 2026-08-06 | $8.92M derived: sum of 3 quarters · filed 2026-08-06 | $14.10M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $3.22M 10-Q · filed 2026-05-12 | $5.79M derived: sum of 2 quarters · filed 2026-05-12 | $10.96M derived: sum of 3 quarters · filed 2026-05-12 | $14.63M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $2.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.75M derived: sum of 2 quarters · filed 2026-03-05 | $11.42M derived: sum of 3 quarters · filed 2026-08-06 | $14.96M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $5.18M 10-Q · filed 2025-11-13 | $8.85M derived: sum of 2 quarters · filed 2026-08-06 | $12.39M 10-Q · filed 2025-11-13 | $14.83M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $3.67M 10-Q · filed 2026-08-06 | $3.92M 10-Q · filed 2025-08-12 | $6.69M 10-Q · filed 2026-08-06 | $7.22M 10-Q · filed 2025-08-12 | $9.65M derived: sum of 3 quarters · filed 2026-08-06 | $13.87M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $3.02M 10-Q · filed 2026-05-12 | $3.30M 10-Q · filed 2025-05-15 | $5.98M derived: sum of 2 quarters · filed 2026-05-12 | $10.20M derived: sum of 3 quarters · filed 2026-05-12 | $14.87M derived: sum of 4 quarters · filed 2026-05-12 | |||
| 2024-12-31 | $2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $7.18M derived: sum of 2 quarters · filed 2026-03-05 | $11.84M derived: sum of 3 quarters · filed 2026-03-05 | $17.69M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $4.22M 10-Q · filed 2025-11-13 | $8.88M derived: sum of 2 quarters · filed 2025-11-13 | $14.73M 10-Q · filed 2025-11-13 | $22.50M derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | $4.67M 10-Q · filed 2025-08-12 | $10.51M 10-Q · filed 2025-08-12 | $10.52M 10-Q · filed 2024-08-14 | $18.28M derived: sum of 3 quarters · filed 2025-08-12 | $27.79M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $5.84M 10-K/A · filed 2025-05-30 | $5.86M 10-Q · filed 2024-05-15 | $13.61M derived: sum of 2 quarters · filed 2025-05-30 | $23.12M derived: sum of 3 quarters · filed 2025-05-30 | $30.00M derived: sum of 4 quarters · filed 2025-05-30 | |||
| 2023-12-31 | $7.77M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-05-30 | $17.27M derived: sum of 2 quarters · filed 2025-05-30 | $24.16M derived: sum of 3 quarters · filed 2025-05-30 | $29.84M 10-K/A · filed 2025-05-30 | $29.51M 10-K · filed 2024-04-11 | |||
| 2023-09-30 | $9.51M 10-Q · filed 2024-11-14 | $9.37M 10-Q · filed 2023-11-14 | $16.39M derived: sum of 2 quarters · filed 2024-11-14 | $22.07M 10-Q · filed 2024-11-14 | $21.87M 10-Q · filed 2023-11-14 | $28.30M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $6.89M 10-Q · filed 2024-08-14 | $12.50M 10-Q · filed 2024-08-14 | $18.80M derived: sum of 3 quarters · filed 2024-08-14 | $23.60M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $5.64M 10-Q · filed 2024-05-15 | $11.91M derived: sum of 2 quarters · filed 2024-05-15 | $16.72M derived: sum of 3 quarters · filed 2024-05-15 | |||||
| 2022-12-31 | $6.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-11 | $11.07M derived: sum of 2 quarters · filed 2024-04-11 | $21.36M 10-K · filed 2024-04-11 | |||||
| 2022-09-30 | $4.81M 10-Q · filed 2023-11-14 | $15.09M 10-Q · filed 2023-11-14 |